90B Stock Overview
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
SOPHiA GENETICS SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.00 |
| 52 Week High | US$5.10 |
| 52 Week Low | US$2.08 |
| Beta | 1.17 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 25.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| 90B | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | 1.2% |
| 1Y | n/a | -25.9% | 2.0% |
Return vs Industry: Insufficient data to determine how 90B performed against the German Healthcare Services industry.
Return vs Market: Insufficient data to determine how 90B performed against the German Market.
Price Volatility
| 90B volatility | |
|---|---|
| 90B Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 3.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 90B has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 90B's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 430 | Jurgi Camblong | www.sophiagenetics.com |
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.
SOPHiA GENETICS SA Fundamentals Summary
| 90B fundamental statistics | |
|---|---|
| Market cap | €306.06m |
| Earnings (TTM) | -€73.59m |
| Revenue (TTM) | €58.12m |
5.3x
P/S Ratio-4.2x
P/E RatioIs 90B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 90B income statement (TTM) | |
|---|---|
| Revenue | US$62.37m |
| Cost of Revenue | US$19.46m |
| Gross Profit | US$42.91m |
| Other Expenses | US$121.89m |
| Earnings | -US$78.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -1.21 |
| Gross Margin | 68.80% |
| Net Profit Margin | -126.63% |
| Debt/Equity Ratio | 0% |
How did 90B perform over the long term?
See historical performance and comparison